Recent News

• 03.24.2025 - Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
• 03.19.2025 - Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
• 03.05.2025 - Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth
• 03.05.2025 - Kamada Declares Special Cash Dividend of $0.20 Per Share
• 02.26.2025 - Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
• 01.22.2025 - Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
• 01.08.2025 - Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025

Recent Filings

• 03.19.2025 - EX-99.1 EX-99.1
• 03.19.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.05.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.05.2025 - EX-99.1 EX-99.1
• 03.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.05.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.26.2025 - EX-99.1 EX-99.1
• 01.22.2025 - EX-99.1 EX-99.1
• 01.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]